The upfront lipid-lowering combination therapy of statins and ezetimibe vs statin monotherapy in the reduction of cardiovascular outcomes. A meta-analysis.

被引：0
|
作者：
Banach, M. [1 ]
Jaiswal, V [2 ]
Ang, S. P. [3 ]
Sawhney, A. [4 ]
Deb, N. [5 ]
Penson, P. [6 ]
Toth, P. [7 ]
机构：
[1] Med Univ Lodz, Dept Prevent Cardiol & Lipidol, Lodz, Poland
[2] Larkin Community Hosp, Miami, FL USA
[3] Rutgers Hlth, Internal Med, Community Med Ctr, Newark, NJ USA
[4] Crozer Chester Med Ctr, Dept Internal Med, Upland, PA USA
[5] North Bengal Med Coll, Siliguri, India
[6] Liverpool John Moores Univ, Fac Hlth & Appl Social Sci, Liverpool, England
[7] Johns Hopkins Univ, Sch Med, Dept Cardiol, Baltimore, MD USA
来源：
EUROPEAN HEART JOURNAL | 2024年 / 45卷
关键词：
D O I：
10.1093/eurheartj/ehae666.2873
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Effect of ezetimibe-statin combination therapy vs. statin monotherapy on coronary atheroma phenotype and lumen stenosis in patients with coronary artery disease: a meta-analysis and trial sequential analysis
    Zhang, Yun-Jing
    Xu, Min
    Duan, Ji-Qiang
    Wang, De-Jin
    Han, Shi-Liang
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [32] More- vs. Less-Intensive Lipid Lowering Therapy: Systematic Review and a Meta-Analysis.
    Toyota, Toshiaki
    Morimoto, Takeshi
    Yamashita, Yugo
    Shiomi, Hiroki
    Kato, Takao
    Makiyama, Takeru
    Nakagawa, Yasuaki
    Saito, Naritatsu
    Shizuta, Satoshi
    Ono, Koh
    Kimura, Takeshi
    CIRCULATION, 2018, 138
  • [33] Efficacy and safety of statins and exercise combination therapy compared to statin monotherapy in patients with dyslipidaemia: A systematic review and meta-analysis
    Gui, Ya-jun
    Liao, Cai-xiu
    Liu, Qiong
    Guo, Yuan
    Yang, Tao
    Chen, Jing-yuan
    Wang, Ya-ting
    Hu, Jia-hui
    Xu, Dan-yan
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2017, 24 (09) : 907 - 916
  • [34] Association of lowering apolipoprotein B with cardiovascular outcomes across various lipid-lowering therapies: Systematic review and meta-analysis of trials
    Khan, Safi U.
    Khan, Muhammad U.
    Valavoor, Shahul
    Khan, Muhammad Shahzeb
    Okunrintemi, Victor
    Mamas, Mamas A.
    Leucker, Thorsten M.
    Blaha, Michael J.
    Michos, Erin D.
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2020, 27 (12) : 1255 - 1268
  • [35] Comparison of Effectiveness of High Dose Statin Monotherapy With Combination of Statin and Ezetimibe to Prevent Cardiovascular Events in Patients With Acute Coronary Syndrome: A Systematic Review and Meta-Analysis
    Damarpally, Nanush
    Sinha, Tanya
    Nunez, Michelle Maricela
    Guntha, Manisha
    Soe, Thin M.
    Chaudhari, Sandipkumar S.
    Ibrahim, Roba A.
    Hirani, Shamsha
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (03)
  • [36] Medication Adherence/Persistence and Demographics of Japanese Dyslipidemia Patients on Statin-Ezetimibe as a Separate Pill Combination Lipid-Lowering Therapy An Observational Pharmacy Claims Database Study
    Umeda, Tatsuya
    Hayashi, Ai
    Fujimoto, Go
    Piao, Yi
    Matsui, Nobutomo
    Tokita, Shigeru
    CIRCULATION JOURNAL, 2019, 83 (08) : 1689 - +
  • [37] Comparative efficacy of non-statin lipid-lowering therapies in patients with hypercholesterolemia at increased cardiovascular risk: a network meta-analysis
    Burnett, Heather
    Fahrbach, Kyle
    Cichewicz, Allie
    Jindal, Ramandeep
    Tarpey, Jialu
    Durand, Adeline
    Di Domenico, Maximiliano
    Reichelt, Andreas
    Viljoen, Adie
    CURRENT MEDICAL RESEARCH AND OPINION, 2022, 38 (05) : 777 - 784
  • [38] Moderate-intensity statin combined with ezetimibe versus high-intensity statin monotherapy for secondary cardiovascular risk reduction: a systematic review and meta-analysis
    Cani, A.
    Ayyalu, T.
    Klaassen, J.
    Turch, H.
    Loyola, J.
    Huang, E.
    Gewehr, D.
    Kritya, M.
    Martignoni, F.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [39] Moderate-intensity statin combined with ezetimibe versus high-intensity statin monotherapy for secondary cardiovascular risk reduction: a systematic review and meta-analysis
    Cani, A.
    Ayyalu, T.
    Klaassen, J.
    Turch, H.
    Loyola, J.
    Huang, E.
    Gewehr, D.
    Kritya, M.
    Martignoni, F.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [40] Reduction in Recurrent Cardiovascular Events With Intensive Lipid-Lowering Statin Therapy Compared With Moderate Lipid-Lowering Statin Therapy After Acute Coronary Syndromes From the PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) Trial
    Murphy, Sabina A.
    Cannon, Christopher P.
    Wiviott, Stephen D.
    McCabe, Carolyn H.
    Braunwald, Eugene
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 54 (25) : 2358 - 2362
12345